Providence Therapeutics
PrivateLast Round
Grant
Dec 7, 2021
Total Funding Raised
$9.62M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Providence Therapeutics is a biotechnology company that develops messenger RNA (mRNA) medicines for cancer treatment and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Providence Therapeutics Comparables
Compare Providence Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PopVax | 85% | |
| Stemirna Therapeutics | 79% | |
| Abogen Biosciences | 79% |
Providence Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 7, 2021 | ||||
| Grant | Jan 21, 2021 | ||||
| Grant | Oct 1, 2020 |
Key People
Founding team and executive leadership
Providence Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Next Generation Manufacturing Canada (NGen) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 291% MoM, reaching 10.6K.
- Aug 3, 2026
Open roles increased to 26, 45% of headcount.
Providence Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Providence Therapeutics's valuation, stock price, and market status.
Is Providence Therapeutics a public or private company?
Providence Therapeutics is a private company.
What is the current stock price of Providence Therapeutics?
Providence Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Providence Therapeutics worth (valuation)?
Valuation information for Providence Therapeutics is not publicly available.
Can I buy Providence Therapeutics stock?
Providence Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Providence Therapeutics's last funding round?
Providence Therapeutics's most recent funding round was Grant on December 7, 2021.
Who are the main investors in Providence Therapeutics?
Key investors in Providence Therapeutics include National Research Council Canada Industrial Research Assistance Program, Bill & Melinda Gates Foundation, Next Generation Manufacturing Canada (NGen).
Will Providence Therapeutics IPO soon?
No public IPO plans have been announced for Providence Therapeutics.
How can I track Providence Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Providence Therapeutics's secondary market activity and sign up for updates.